Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: J Addict Med. 2019 Jan-Feb;13(1):28–34. doi: 10.1097/ADM.0000000000000441

Table 3.

Organizational resource needs and physician recruitment practices by pharmacotherapy adoption

General Resource Needs
Mean (SD)
Medical Resource Needs
Mean (SD)
Physician Outreach Activities
Mean (SD)
Dedicated Resources for Recruitment
Mean (SD)
Provides buprenorphine-naloxone 4.47 (0.58) 3.97 (1.17) 2.61*** (1.05) 2.19*** (1.57)
Does not provide buprenorphine-naloxone 4.24 (0.88) 3.88 (1.22) 1.77 (0.93) 1.39 (0.99)
Provides buprenorphine (without naloxone) 4.51 (0.62) 4.04 (1.07) 2.63*** (1.02) 2.16* (1.57)
Does not provide buprenorphine 4.28 (0.78) 3.89 (1.25) 1.98 (1.03) 1.65 (1.26)
Provides oral naltrexone 4.40 (0.80) 4.04 (1.17) 2.60*** (1.03) 2.03(1.45)
Does not provide oral naltrexone 4.32 (0.67) 3.84 (1.20) 1.92 (1.02) 1.66 (1.35)
Provides extended-release naltrexone 4.43 (0.64) 3.97 (1.17) 2.49*** (1.06) 1.98 (1.21)
Does not provide extended-release naltrexone 4.26 (0.87) 3.88 (1.22) 1.76 (0.95) 1.59 (1.49)
Provides methadone 4.63 (0.53) 4.01 (1.15) 2.83** (1.02) 1.52 (1.21)
Does not provide methadone 4.31 (0.76) 3.85 (1.23) 2.15 (1.05) 1.91 (1.44)

Notes. Difference between adopters and non-adopters,

*

p<.05,

**

p<.01,

***

p<.001, using independent samples t-tests (two-tailed).